Closing the stable door after the horse has bolted – should we be treating people with immune-tolerant chronic hepatitis B to prevent hepatocellular carcinoma?

Posted on February 20, 2020 by Gastroenterology Journal
This entry was posted in News. Bookmark the permalink.